OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
Georgina V. Long, Alexander M. Menzies, Richard A. Scolyer
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3236-3248
Closed Access | Times Cited: 41
Georgina V. Long, Alexander M. Menzies, Richard A. Scolyer
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3236-3248
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Cutaneous melanoma
Georgina V. Long, Susan M. Swetter, Alexander M. Menzies, et al.
The Lancet (2023) Vol. 402, Iss. 10400, pp. 485-502
Closed Access | Times Cited: 303
Georgina V. Long, Susan M. Swetter, Alexander M. Menzies, et al.
The Lancet (2023) Vol. 402, Iss. 10400, pp. 485-502
Closed Access | Times Cited: 303
Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy
Suzanne L. Topalian, Patrick M. Forde, Leisha A. Emens, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1551-1566
Open Access | Times Cited: 129
Suzanne L. Topalian, Patrick M. Forde, Leisha A. Emens, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1551-1566
Open Access | Times Cited: 129
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma
Bin Lian, Z. Li, Nan Wu, et al.
Annals of Oncology (2023)
Open Access | Times Cited: 24
Bin Lian, Z. Li, Nan Wu, et al.
Annals of Oncology (2023)
Open Access | Times Cited: 24
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 1/2 trial
Reinhard Dummer, Caroline Robert, Richard A. Scolyer, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
Reinhard Dummer, Caroline Robert, Richard A. Scolyer, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
Advances in targeted therapy and immunotherapy for melanoma (Review)
Ziyao Qin, Mei Zheng
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 15
Ziyao Qin, Mei Zheng
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 15
Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Amelia M. Taylor, Janet McKeown, Florentia Dimitriou, et al.
European Journal of Cancer (2024) Vol. 199, pp. 113561-113561
Closed Access | Times Cited: 5
Amelia M. Taylor, Janet McKeown, Florentia Dimitriou, et al.
European Journal of Cancer (2024) Vol. 199, pp. 113561-113561
Closed Access | Times Cited: 5
Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance
Aurélie H. Benfield, Felicitas Vernen, Reuben S. E. Young, et al.
Pharmacological Research (2024) Vol. 207, pp. 107298-107298
Open Access | Times Cited: 5
Aurélie H. Benfield, Felicitas Vernen, Reuben S. E. Young, et al.
Pharmacological Research (2024) Vol. 207, pp. 107298-107298
Open Access | Times Cited: 5
Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial
Yan Zheng, Guanghui Liang, Dongfeng Yuan, et al.
Cancer Communications (2024)
Open Access | Times Cited: 5
Yan Zheng, Guanghui Liang, Dongfeng Yuan, et al.
Cancer Communications (2024)
Open Access | Times Cited: 5
Integrated Single-Cell Sequencing for the Development of a Gja4-Based Precision Immuno-Prognostic Model in Melanoma
Yantao Ding, Shengxiu Liu, Zaixing Wang, et al.
(2025)
Closed Access
Yantao Ding, Shengxiu Liu, Zaixing Wang, et al.
(2025)
Closed Access
The role of mitophagy-related genes in prognosis and immunotherapy of cutaneous melanoma: a comprehensive analysis based on single-cell RNA sequencing and machine learning
Jun Tian, Lei Zhang, Kexin Shi, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
Jun Tian, Lei Zhang, Kexin Shi, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy
Sarah E. Lochrin, Hannah L. Kalvin, James W. Smithy, et al.
JAMA Oncology (2025)
Closed Access
Sarah E. Lochrin, Hannah L. Kalvin, James W. Smithy, et al.
JAMA Oncology (2025)
Closed Access
Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors
Yan Zhang, Ziting Qu, Hau Xuan Nguyen, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2531-2544
Open Access
Yan Zhang, Ziting Qu, Hau Xuan Nguyen, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2531-2544
Open Access
The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature
Giulia Spagnol, Eleonora Ghisoni, Matteo Morotti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7070-7070
Open Access | Times Cited: 4
Giulia Spagnol, Eleonora Ghisoni, Matteo Morotti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7070-7070
Open Access | Times Cited: 4
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
Wei Wei, Yongfu Cao, Xin Lü, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Wei Wei, Yongfu Cao, Xin Lü, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advances in Lymphatic Imaging for Sentinel Lymph Node Identification in Oncologic Surgery
Marcus Wölffer, Cédric Zubler
IntechOpen eBooks (2025)
Closed Access
Marcus Wölffer, Cédric Zubler
IntechOpen eBooks (2025)
Closed Access
Overcoming common emerging barriers to effective neoadjuvant immunotherapies
Sophia Sokol, Marijo Bilušić
Expert Review of Anticancer Therapy (2025), pp. 1-11
Closed Access
Sophia Sokol, Marijo Bilušić
Expert Review of Anticancer Therapy (2025), pp. 1-11
Closed Access
Longitudinal analysis reveals dynamic changes in histopathologic features in responders to neoadjuvant treatment in a stage III BRAF-mutant melanoma cohort
Jorja Braden, Alison Potter, Robert V. Rawson, et al.
Modern Pathology (2025), pp. 100776-100776
Closed Access
Jorja Braden, Alison Potter, Robert V. Rawson, et al.
Modern Pathology (2025), pp. 100776-100776
Closed Access
Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment
Piotr Rutkowski, Mario Mandalà
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 3, pp. 107969-107969
Closed Access | Times Cited: 3
Piotr Rutkowski, Mario Mandalà
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 3, pp. 107969-107969
Closed Access | Times Cited: 3
The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer
Chaolin Li, Qin Li, Li Li, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 3
Chaolin Li, Qin Li, Li Li, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 3
Two decades of advances in clinical oncology — lessons learned and future directions
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3
Multifunctional Near-Infrared Dye IR-817 Encapsulated in Albumin Nanoparticles for Enhanced Imaging and Photothermal Therapy in Melanoma
Jianv Wang, Hongye Liao, Jieming Ban, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4949-4967
Open Access | Times Cited: 7
Jianv Wang, Hongye Liao, Jieming Ban, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4949-4967
Open Access | Times Cited: 7
Mapping the single cell spatial immune landscapes of the melanoma microenvironment
Jamie Magrill, Dan Moldoveanu, J. Gu, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 4, pp. 301-312
Open Access | Times Cited: 2
Jamie Magrill, Dan Moldoveanu, J. Gu, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 4, pp. 301-312
Open Access | Times Cited: 2
Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia
Illaa Smesseim, Paul Baas
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 4, pp. 547-550
Open Access | Times Cited: 2
Illaa Smesseim, Paul Baas
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 4, pp. 547-550
Open Access | Times Cited: 2
Tackling the Immunotherapy Conundrum: Advances and Challenges for Operable Non-Small-Cell Lung Cancer Treatment
Fouad Attieh, Antoine Chartouni, Marc Boutros, et al.
Immunotherapy (2023) Vol. 15, Iss. 16, pp. 1415-1428
Closed Access | Times Cited: 4
Fouad Attieh, Antoine Chartouni, Marc Boutros, et al.
Immunotherapy (2023) Vol. 15, Iss. 16, pp. 1415-1428
Closed Access | Times Cited: 4
Management of Locoregional Melanoma
S. Swisher, Keith A. Delman
Advances in Oncology (2024) Vol. 4, Iss. 1, pp. 9-18
Closed Access | Times Cited: 1
S. Swisher, Keith A. Delman
Advances in Oncology (2024) Vol. 4, Iss. 1, pp. 9-18
Closed Access | Times Cited: 1
